The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

AG-J-24754     5-ethyl-5-(4-hydroxyphenyl)- 1,3-diazinane...

Synonyms: CHEMBL1908024, NSC-159266, AC1L1TTD, AC1Q6GBZ, CTK4H9034, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of NSC 159266

 

High impact information on NSC 159266

 

Biological context of NSC 159266

 

Anatomical context of NSC 159266

 

Gene context of NSC 159266

 

Analytical, diagnostic and therapeutic context of NSC 159266

References

  1. The metabolism and excretion of enzyme-inducing doses of phenobarbital by rats with bile fistulas. Levin, S.S., Vars, H.M., Schleyer, H., Cooper, D.Y. Xenobiotica (1986) [Pubmed]
  2. Pharmacokinetic modeling of the anticonvulsant action of phenobarbital in rats. Dingemanse, J., van Bree, J.B., Danhof, M. J. Pharmacol. Exp. Ther. (1989) [Pubmed]
  3. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment. Xiong, H., Suzuki, H., Sugiyama, Y., Meier, P.J., Pollack, G.M., Brouwer, K.L. Drug Metab. Dispos. (2002) [Pubmed]
  4. GC and GC-mass spectrometric determination of p-hydroxyphenobarbital extracted from plasma, urine, and hepatic microsomes. Kapetanović, I.M., Kupferberg, H.J. Journal of pharmaceutical sciences. (1981) [Pubmed]
  5. Simultaneous analysis of phenobarbital and p-hydroxyphenobarbital in biological fluids by GLC-chemical-ionization mass spectrometry. Patel, I.H., Levy, R.H., Neal, J.M., Trager, W.F. Journal of pharmaceutical sciences. (1980) [Pubmed]
  6. Rapid quantitative determination of underivatized carbamazepine, phenytoin, phenobarbital and p-hydroxyphenobarbital in biological fluids by packed column gas chromatography. Riva, R., Albani, F., Baruzzi, A. J. Chromatogr. (1980) [Pubmed]
  7. Phenobarbital disposition in the neonate. Garrettson, L.K. Addictive diseases. (1975) [Pubmed]
  8. Comparison of the effects of phenobarbital and its hydroxylated metabolites on drug-metabolizing enzymes during ontogenesis. Cresteil, T., Mahu, J.L., Beaune, P., Columelli, S., Leroux, J.P. Pediatric pharmacology (New York, N.Y.) (1981) [Pubmed]
  9. P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism. Hadama, A., Ieiri, I., Morita, T., Kimura, M., Urae, A., Irie, S., Kaneda, T., Mamiya, K., Tashiro, N., Higuchi, S., Otsubo, K. Therapeutic drug monitoring. (2001) [Pubmed]
  10. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite. Sarhan, F., Engasser, J.M., Batt, A.M., Magdalou, J., Siest, G. European journal of drug metabolism and pharmacokinetics. (1981) [Pubmed]
 
WikiGenes - Universities